Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling.

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Exosome Biology

Background:

• Congenital heart disease can cause severe right ventricular heart failure (RVHF).
• Aggregated c-kit+ progenitor cells (CPCs) have shown promise in repairing RVHF, potentially via exosome-mediated effects.
• Understanding the specific mechanisms of CPC-derived exosomes is crucial for therapeutic development.

Purpose of the Study:

• To correlate the microRNA (miRNA) content of 2D and 3D CPC-derived exosomes with in vitro angiogenesis and antifibrosis responses.
• To develop a predictive model using partial least squares regression (PLSR) to link exosome miRNA profiles to biological outcomes.
• To validate the predictive capability of the PLSR model for in vivo therapeutic responses.

Main Methods:

• Utilized partial least squares regression (PLSR) to analyze miRNA content from monolayer (2D) and aggregated (3D) CPC exosomes.
• Reduced data dimensionality to identify top 40 miRNAs significantly associated with in vitro angiogenesis and antifibrosis.
• Performed target pathway analysis to identify biological pathways modulated by these key miRNAs.

Main Results:

• PLSR successfully identified a set of 40 miRNAs strongly correlated with in vitro angiogenesis and antifibrosis.
• Target pathway analysis revealed significant enrichment in cardiac angiogenesis and fibrosis pathways.
• The developed PLSR model accurately predicted in vivo angiogenesis and fibrosis responses to exosome treatment, correlating well with published data.

Conclusions:

• Exosome miRNA profiles can be modeled to predict therapeutic efficacy in RVHF.
• PLSR modeling of exosome miRNA content offers a powerful tool for preclinical assessment of CPC therapies.
• This approach has the potential to accelerate the development of novel stem cell-based treatments for heart failure.